Larger, more rigorous clinical trials of gadolinium-texaphyrin have just started, and the approach is also being tried for prostate, pancreatic and neck tumours.
ECONOMIST: Medicinal light-swords
2.
Lutetium-texaphyrin has proved successful in shrinking atherosclerotic lesions in leg arteries.
ECONOMIST: Medicinal light-swords
3.
Pharmacyclics's drug, called lutetium-texaphyrin, is activated by red light.